Skip to content
10-Q

Quarterly Report

CARDIOVASCULAR SYSTEMS, INC.

0001180145-22-000004

← back to feed
Filed
Feb 3, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Jan 31, 2022 40.58M sh
Cash And Equivalents Q2 2022 · Dec 31, 2021 $65.87M
Cash And Equivalents Q2 2022 · Jun 30, 2021 $71.07M
Cash And Equivalents Q2 2022 · Dec 31, 2020 $73.78M
Cash And Equivalents Q2 2022 · Jun 30, 2020 $185.46M
Current Liabilities Q2 2022 · Dec 31, 2021 $41.88M
Current Liabilities Q2 2022 · Jun 30, 2021 $54.65M
Total Liabilities Q2 2022 · Dec 31, 2021 $66.88M
Total Liabilities Q2 2022 · Jun 30, 2021 $81.61M
Current Assets Q2 2022 · Dec 31, 2021 $248M
Current Assets Q2 2022 · Jun 30, 2021 $284.67M
Total Assets Q2 2022 · Dec 31, 2021 $326.4M
Total Assets Q2 2022 · Jun 30, 2021 $352.57M
Shares Diluted Q2 2022 · Dec 31, 2020 38.81M sh
Shares Diluted Q2 2022 · Dec 31, 2020 38.75M sh
Capex Q2 2022 · Dec 31, 2020 $1.99M
Operating Cash Flow Q2 2022 · Dec 31, 2020 −$467K
Stockholders Equity Q2 2022 · Dec 31, 2020 $273.83M
Stockholders Equity Q2 2022 · Sep 30, 2020 $268.41M
Stockholders Equity Q2 2022 · Jun 30, 2020 $268.79M
Eps Diluted Q2 2022 · Dec 31, 2020 $0.00
Eps Diluted Q2 2022 · Dec 31, 2020 −$0.06
Eps Basic Q2 2022 · Dec 31, 2020 $0.00
Eps Basic Q2 2022 · Dec 31, 2020 −$0.06
Sga Expense Q2 2022 · Dec 31, 2020 $40.06M
Sga Expense Q2 2022 · Dec 31, 2020 $80.34M
Rd Expense Q2 2022 · Dec 31, 2020 $9.6M
Rd Expense Q2 2022 · Dec 31, 2020 $18.65M
Net Income Q2 2022 · Dec 31, 2020 −$56K
Net Income Q2 2022 · Dec 31, 2020 −$2.13M
Net Income Q2 2022 · Sep 30, 2020 −$2.08M
Operating Income Q2 2022 · Dec 31, 2020 $283K
Operating Income Q2 2022 · Dec 31, 2020 −$1.38M
Gross Profit Q2 2022 · Dec 31, 2020 $50.25M
Gross Profit Q2 2022 · Dec 31, 2020 $98.23M
Cost Of Revenue Q2 2022 · Dec 31, 2020 $13.92M
Cost Of Revenue Q2 2022 · Dec 31, 2020 $26.48M
Revenue Q2 2022 · Dec 31, 2020 $64.17M
Revenue Q2 2022 · Dec 31, 2020 $124.71M